Perspective Articles

Interrogating the molecular genetics of chronic myeloproliferative malignancies for personalized management in 2021

Tufts University Medical Center, Boston, MA, USA; University of Buckingham Medical School, Buckingham
MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford
Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
Orbassano University Hospital, Turin
University of California Irvine, Irvine, CA
Frederick Hutchinson Cancer Research Center, Seattle, WA
Haematologica Early view Mar 4, 2021 https://doi.org/10.3324/haematol.2020.267252